Intervention 1: Intervention group: Before starting the main intervention, all the selected people enter the Run-in period for two weeks, to collect complete information about the patients' food intak

3 trials

Sponsors

Tehran University of Medical Sciences

Conditions

End Stage Renal Disease. Chronic kidney disease, stage 5Kidney disease in the stage before dialysis (stage 3 and 4). Chronic kidney disease, unspecified

Phase 3

The effects of melatonin supplementation on oxidative stress, inflammatory biomarkers and lipid profile in diabetic patients with chronic kidney disease- a randomized trial

Active, not recruitingIRCT20170202032367N9

Tehran University of Medical SciencesKidney disease in the stage before dialysis (stage 3 and 4). Chronic kidney disease, unspecified

Start: 2023-09-23Target: 48Updated: 2023-08-21

The effects of L-arginine supplementation in diabetic hemodialysis patients

Active, not recruitingIRCT20170202032367N12

Tehran University of Medical SciencesEnd Stage Renal Disease. Chronic kidney disease, stage 5

Start: 2026-04-09Target: 52Updated: 2026-02-02

The effects of coenzyme Q10 supplementation in diabetic hemodialysis patients

Active, not recruitingIRCT20170202032367N13

Tehran University of Medical SciencesEnd Stage Renal Disease. Chronic kidney disease, stage 5

Start: 2026-04-09Target: 48Updated: 2026-02-02

Related Papers

Effects of melatonin supplementation on metabolic parameters, oxidative stress, and inflammatory biomarkers in diabetic patients with chronic kidney disease: study protocol for a double-blind, randomized controlled trial

Trials2024-11-132 citations